The above table “Personnel by reported organisational unit” displays personnel numbers grouped according to the same Group structure as is used in the compilation of data for this report. This structure differs from the grouping used in Orion’s IFRS-based financial reporting, in which the numbers of employees are presented per business segment and division. The figures reported for subsidiaries include the foreign Orion Pharma companies for marketing pharmaceuticals and the foreign Orion Diagnostica companies for marketing diagnostic products. The personnel numbers have been converted to full-time employees according to the same principles as those applied in IFRS reporting.

Orion Corporation’s personnel mostly comprises of employees working in pharmaceutical manufacturing, research and development, marketing, business support functions and in financial administration, corporate functions and management.

In 2009, Orion’s total workforce was reduced by about 205 people as part of restructuring to brace for tougher competition and the expiry of certain key patents. Most of the reductions took place in the Finnish organisations for pharmaceutical R&D. Despite the related operationalchanges, working atmosphere has remained positive.

Workforce in the sales subsidiaries and offices located in over 20 European countries is growing.